Syntara Limited
Business Services · Australia · 51-200 Employees
View Company Info for Free
Overview
Headquarters
PO Box, Frenchs Forest, New South Wales,...Phone Number
+61 294547200Website
www.syntaratx.com.auRevenue
$6.2 MillionStock Symbol
SNTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Syntara Limited
Syntara is a clinical-stage drug development company focused on creating innovative treatments for blood-related cancers and conditions associated with inflammation and fibrosis. The company specializes in addressing extracellular matrix dysfunction through its expertise in amine oxidase chemistry. Its lead candidate, amsulostat, is currently undergoing Phase 2 trials for myelofibrosis, with additional studies in myelodysplastic syndrome and other chronic diseases. Syntara aims to provide life-changing therapies for patients with high unmet medical needs.Explore more
Syntara Limited Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Syntara Limited your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Syntara Limited has new funding data
Click to see if Syntara Limited had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Syntara Limited, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Syntara Limited recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Syntara Limited
Check if Syntara Limited has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Syntara Limited launches new products
Check out if Syntara Limited is spiking on competitors!
Recommended Actions
Find VP level buyers at Syntara Limited
Find 2 more new buyers
Compare Similar Companies to Syntara Limited
Compare insights from companies similar to Syntara Limited, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Syntara Limited is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Syntara Limited is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Syntara Limited.
Syntara Limited News & Media
Syntara Limited (PMXSF) Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates Transcript
Syntara Limited (PMXSF) Discusses 2026 Clinical Pipeline Outlook and Anticipated Trial Updates February 2, 2026 7:01 PM ESTCompany ParticipantsGary Phillips...We're Keeping An Eye On Syntara's (ASX:SNT) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...Syntara Limited (PMXSF) Discusses Progress and Future Plans for Skin Scarring Program Transcript
Syntara Limited (OTCPK:PMXSF) Discusses Progress and Future Plans for Skin Scarring Program November 25, 2025 7:00 PM ESTCompany ParticipantsGary Phillips -...Syntara Limited (PMXSF) Shareholder/Analyst Call Transcript
Syntara Limited (OTCPK:PMXSF) Shareholder/Analyst Call September 29, 2025 9:00 PM EDTCompany ParticipantsGary Phillips - CEO, MD & DirectorConference...
Read more news
Top Business Services Companies
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Syntara Limited
Sign Up For FreeTo access detailed company insights
Syntara is a clinical-stage drug development company focused on creating innovative treatments for blood-related cancers and conditions associated with inflammation and fibrosis. The company specializes in addressing extracellular matrix dysfunction through its expertise in amine oxidase chemistry. Its lead candidate, amsulostat, is currently under... Read More
